Skip to main content
PRCT
NASDAQ Industrial Applications And Services

PROCEPT BioRobotics Appoints Former Shockwave Medical CFO Daniel Puckett to Board and Audit Committee

AI Analysis by WiseekReviewed by Editorial Team
Sentiment info
Positive
Importance info
7
Price
$25.35
Mkt Cap
$1.429B
52W Low
$19.35
52W High
$66.85
Market data snapshot near publication time

summarizeSummary

PROCEPT BioRobotics has expanded its board and appointed Daniel Puckett, former CFO of Shockwave Medical, as an independent director and member of the Audit Committee, enhancing financial and industry expertise.


check_boxKey Events

  • Board Expansion

    The Board of Directors approved an increase in its size from eight to nine members.

  • New Independent Director Appointed

    Mr. Daniel Puckett was appointed as a new Class III independent member of the Board, with his initial term expiring at the 2027 annual meeting.

  • Audit Committee Appointment

    Mr. Puckett was also appointed as a member of the Audit Committee, effective immediately.

  • Experienced Financial Executive

    Mr. Puckett previously served as Chief Financial Officer of Shockwave Medical, Inc. from April 2016 to February 2024, and held other senior finance roles at various companies, bringing significant medical device and financial expertise.


auto_awesomeAnalysis

PROCEPT BioRobotics has strengthened its corporate governance and financial oversight by appointing Daniel Puckett, a seasoned financial executive with extensive experience in the medical device industry, to its Board of Directors and Audit Committee. Mr. Puckett's background as the former CFO of Shockwave Medical, a leading medical device company, brings valuable strategic and financial expertise, which is particularly important following the company's recent financial reporting and strategic plan disclosures. This move signals a commitment to robust financial management and strategic guidance.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed PRCT - Latest Insights

PRCT
Mar 09, 2026, 7:19 PM EDT
Filing Type: 4
Importance Score:
8
PRCT
Mar 05, 2026, 7:30 PM EST
Filing Type: 8-K
Importance Score:
7
PRCT
Feb 26, 2026, 4:04 PM EST
Filing Type: 10-K
Importance Score:
8
PRCT
Feb 26, 2026, 7:57 AM EST
Filing Type: 8-K
Importance Score:
8
PRCT
Feb 25, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8